» Articles » PMID: 24281597

Evidence-based Medicine: Pressure Sores

Overview
Specialty General Surgery
Date 2013 Nov 28
PMID 24281597
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Learning Objectives: After studying this article, the participant should be able to: 1. Cite risk factors for pressure sore development. 2. Detail the pathophysiology of pressure sores. 3. List the types and classification of pressure sores. 4. Consider the various nonsurgical conservative wound management strategies. 5. Describe the appropriate surgical interventions for each pressure sore type. 6. Understand the causes of recurrent pressure sores and methods of avoiding recurrence.

Summary: Pressure sores are the result of unrelieved pressure, usually over a bony prominence. With an estimated 2.5 million pressure ulcers treated annually in the United States at a cost of $11 billion, pressure sores represent a costly and labor-intensive challenge to the health care system. A comprehensive team approach can address both prevention and treatment of these recalcitrant wounds. Consideration must be given to the patient's medical and socioeconomic condition, as these factors are significantly related to outcomes. Mechanical prophylaxis, nutritional optimization, treatment of underlying infection, and spasm control are essential in management. A variety of pressure sore patterns exist, with surgical approaches directed to maximize future coverage options. A comprehensive approach is detailed in this article to provide the reader with the range of treatment options available.

Citing Articles

The validity and safety of multispectral light emitting diode (LED) treatment on grade 2 pressure ulcer: Double-blinded, randomized controlled clinical trial.

Lim N, Goo H, Yoon S, Ahn J, Hong N, Choi Y PLoS One. 2024; 19(8):e0305616.

PMID: 39178286 PMC: 11343461. DOI: 10.1371/journal.pone.0305616.


GelMA loaded with platelet lysate promotes skin regeneration and angiogenesis in pressure ulcers by activating STAT3.

Jin T, Fu Z, Zhou L, Chen L, Wang J, Wang L Sci Rep. 2024; 14(1):18345.

PMID: 39112598 PMC: 11306777. DOI: 10.1038/s41598-024-67304-2.


Combined treatment of umbilical cord Wharton's jelly-derived mesenchymal stem cells and platelet-rich plasma for a surgical patient with hospital-acquired pressure ulcer: a case report and literature review.

Zhou C, Jiao L, Qiao X, Zhang W, Chen S, Yang C Front Bioeng Biotechnol. 2024; 12:1424941.

PMID: 39045540 PMC: 11263083. DOI: 10.3389/fbioe.2024.1424941.


Reconstructive Surgery of Pressure Injuries in Spinal Cord Injury/Disorder Patients: Retrospective Observational Study and Proposal of an Algorithm for the Flap Choice.

Sgarzani R, Rucci P, Landi S, Battilana M, Capirossi R, Aramini B Healthcare (Basel). 2024; 12(1).

PMID: 38200940 PMC: 10778812. DOI: 10.3390/healthcare12010034.


Mesenchymal Stromal Cell Healing Outcomes in Clinical and Pre-Clinical Models to Treat Pressure Ulcers: A Systematic Review.

Torres-Guzman R, Avila F, Maita K, Garcia J, Sario G, Borna S J Clin Med. 2023; 12(24).

PMID: 38137625 PMC: 10743704. DOI: 10.3390/jcm12247545.